{"title": "Fierce Biotech's 2021 Fierce 15", "author": "Ben Adams", "url": "https://www.fiercebiotech.com/special-report/fierce-biotech-s-2021-fierce-15-0", "hostname": "fiercebiotech.com", "description": "While speaking to a number of venture capitalists this year, we picked their brains on how to choose life science winners. It's never an easy task, and the pandemic has made things much harder because physical meetings have largely been a no-no and research priorities are shifting (surely it's about time) to infectious disease and vaccines. | COVID-19 was inevitably the focus of Fierce 15 last year. This year, it's pretty much more of the same as we see how the sector has and continues to navigate the pandemic while raising cash, running trials, hiring staff, keeping them safe, and making deals during an incredibly difficult 18 months.", "sitename": "FierceBiotech", "date": "2021-09-27", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}